Semler Scientific, Inc.

    Semler Scientific, Inc.

    NNASDAQ:SMLR
    20.33
    USD
    0.00
    (0.00%)
    6.86P/E
    Semler Scientific, Inc.
    NASDAQ:SMLR
    (Nasdaq Stock Market)

    Recent

    price

    20.33

    P/E

    ratio

    6.86

    div

    yld

    - -

    ROIC.AI

    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    0.11
    0.43
    0.48
    0.89
    1.42
    1.45
    2.3
    3.54
    5.09
    5.86
    7.88
    8.43
    10.13
    7.79
    3.34
    Revenue per Share
    -0.67
    -1.01
    -0.47
    -1.1
    -1.72
    -0.5
    -0.28
    0.82
    2.34
    2.13
    2.56
    2.13
    3.06
    5.66
    4.37
    Basic EPS, GAAP
    -0.52
    -0.72
    -0.35
    -1.04
    -1.06
    -0.51
    -0.06
    0.63
    1.71
    2.18
    2.26
    2.27
    3.05
    -22.87
    -39.6
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -1.56
    -2.54
    -1.99
    -3.38
    -4.54
    -4.86
    -4.89
    -3.52
    -0.98
    1.17
    3.7
    5.83
    8.88
    13.93
    10.84
    Book Value per Share
    -0.17
    -1.52
    -1.49
    0.84
    -0.22
    -0.57
    -0.48
    0.69
    2.03
    4.52
    6.77
    8.28
    10.66
    2.23
    -7.25
    Tangible Book Value per Share
    3
    3
    5
    4
    5
    5
    5
    6
    6
    7
    7
    7
    7
    7
    11
    Basic Weighted Avg Shares
    - -
    1
    2
    4
    7
    7
    12
    21
    33
    39
    53
    57
    68
    56
    37
    Sales/Revenue/Turnover
    -562.97
    -201.42
    -93.4
    -119.42
    -120.25
    -29.04
    -6.85
    24.86
    32.68
    41.35
    36.67
    30.35
    33.72
    37.19
    -14.21
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    1
    1
    1
    - -
    Depreciation Expense
    -2
    -3
    -2
    -5
    -9
    -3
    -2
    5
    15
    14
    17
    14
    21
    41
    48
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.52
    - -
    15.04
    11.48
    19.03
    14.59
    14.59
    22.13
    Effective Tax Rate (%)
    -593.67
    -228.61
    -98.2
    -124.21
    -121.43
    -34.36
    -12.13
    23.33
    46.03
    36.28
    32.48
    25.27
    30.19
    72.65
    130.8
    Profit Margin (%)
    -1
    - -
    -1
    3
    -2
    -2
    -2
    3
    6
    22
    41
    42
    60
    16
    26
    Working Capital
    - -
    - -
    - -
    - -
    - -
    3
    2
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    96
    LT Debt
    - -
    -4
    - -
    3
    -1
    -3
    -3
    4
    13
    30
    46
    56
    72
    231
    460
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    234.63
    - -
    62.07
    44.38
    26.61
    29.89
    11.72
    -1.23
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -23.65
    - -
    2,070.51
    104.67
    44.28
    41.4
    50.88
    31.88
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    105.71
    44.68
    41.57
    50.96
    50.52
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    - -
    - -
    20
    LT Borrowings
    96
    96
    96
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    10
    14
    15
    Market Capitalization
    286
    353
    332

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    18
    22
    54
    Cash, Cash Equivalents & STI
    10
    13
    10
    Accounts Receivable, Net
    3
    3
    3
    Inventories
    - -
    1
    - -
    Total Current Liabilities
    36
    37
    27
    Payables & Accruals
    33
    33
    3
    ST Debt
    - -
    - -
    20
    Deferred Revenue
    1
    1
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    43.21%
    90.67%
    221.4%
    Free Cash Flow
    -196.41%
    -167.15%
    -906.46%
    Net Income, GAAP
    -11.24%
    28.28%
    98.7%
    Sales/Revenue/Turnover
    35.63%
    12.98%
    -17.44%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    18
    19
    16
    15
    68
    2024
    16
    14
    14
    12
    56
    2025
    9
    8
    7
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.74
    0.88
    0.82
    0.62
    3.06
    2024
    0.88
    - -
    0.8
    3.64
    5.66
    2025
    -6.74
    5.71
    1.14
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • newsfilecorp.com

      Kuehn Law Encourages Investors of Semler Scientific to Contact Law Firm

    • defenseworld.net

      Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) Price Target at $74.25

    • defenseworld.net

      Generali Asset Management SPA SGR Grows Stock Holdings in Semler Scientific Inc. $SMLR

    • defenseworld.net

      Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) PT at $74.25

    • defenseworld.net

      Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey

    • prnewswire.com

      Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR

    • youtube.com

      Crypto's Hottest Trade Crumples

    • globenewswire.com

      SMLR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Semler Scientific With Strive Asset Management

    • prnewswire.com

      Semler Scientific® to Release Third Quarter 2025 Financial Results

    • globenewswire.com

      Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2025 in Semler Scientific, Inc. Lawsuit – SMLR

    • prnewswire.com

      Semler Scientific Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

    • globenewswire.com

      SMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    • businesswire.com

      SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR

    • prnewswire.com

      INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR

    • prnewswire.com

      SMLR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025

    • prnewswire.com

      Semler Scientific, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR

    • seekingalpha.com

      Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish

    • globenewswire.com

      SEMLER FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Semler Stockholders to Contact the Firm Before October 28th

    • globenewswire.com

      Portnoy Law Firm Announces Class Action on Behalf of Semler Scientific, Inc. Investors

    • businesswire.com

      Deadline Soon: Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz About Securities Fraud Lawsuit